HEALTHCARE RESOURCE UTILIZATION (HRU) OF IMMUNE CHECKPOINT INHIBITORS IN METASTATIC LUNG CANCER PATIENTS

被引：0
|
作者：
Huang, Y. [1 ]
Diaby, V [1 ]
机构：
[1] Univ Florida, Gainesville, FL USA
来源：
VALUE IN HEALTH | 2021年 / 24卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN79
引用
收藏
页码：S34 / S34
页数：1
相关论文
共 50 条
  • [1] HEALTHCARE RESOURCE UTILIZATION ANALYSIS ON IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH METASTATIC LUNG CANCER USING CLAIMS DATABASE
    Huang, Y.
    Diaby, V
    VALUE IN HEALTH, 2020, 23 : S48 - S48
  • [2] COST AND HEALTHCARE RESOURCE UTILIZATION (HRU) RESULTING FROM IMMUNE-RELATED ADVERSE EVENTS (IRAES) AMONG PATIENTS RECEIVING IMMUNE CHECKPOINT INHIBITORS (ICIS)
    Zheng, Y.
    Kim, R.
    Yu, T.
    Dreyfus, J.
    Gayle, J. A.
    Wassel, C. L.
    Phatak, H.
    George, S.
    VALUE IN HEALTH, 2019, 22 : S469 - S469
  • [3] Healthcare Utilization among Cancer Patients Treated with Immune Checkpoint Inhibitors in Taiwan
    Hsu, Chia-Lu
    To, Sheng-Yin
    Lee, Cho-Hao
    Yang, Hui-Wen
    Wen, Yuan-Liang
    Kao, Li-Ting
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 172 - 172
  • [4] Clinical Outcomes, Costs, and Healthcare Resource Utilization in Patients with Metastatic Merkel Cell Carcinoma Treated with Immune Checkpoint Inhibitors vs Chemotherapy
    Zheng, Ying
    Yu, Ting
    Mackey, Rachel H.
    Gayle, Julie A.
    Wassel, Christina L.
    Phatak, Hemant
    Kim, Ruth
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2021, 13 : 213 - 226
  • [5] Cardiotoxicity of Immune Checkpoint Inhibitors in Patients with Lung Cancer
    Chitturi, Kalyan R.
    Araujo-Gutierrez, Raquel
    McLean, Edward T.
    Xu, Jiaqiong
    Bhimaraj, Arvind
    Guha, Ashrith
    Hussain, Imad
    Trachtenberg, Barry H.
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (08) : S50 - S50
  • [6] Immune checkpoint inhibitors in lung cancer
    Koleczko, S.
    Wolf, J.
    INTERNIST, 2020, 61 (07): : 676 - 681
  • [7] Immune checkpoint inhibitors for metastatic bladder cancer
    Cubelli, Marta
    Di Nunno, Vincenzo
    Rihawi, Karim
    Massari, Francesco
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S720 - S732
  • [8] Immune checkpoint inhibitors for metastatic bladder cancer
    Massari, Francesco
    Di Nunno, Vincenzo
    Cubelli, Marta
    Santoni, Matteo
    Fiorentino, Michelangelo
    Montironi, Rodolfo
    Cheng, Liang
    Lopez-Beltran, Anto
    Battelli, Nicola
    Ardizzoni, Andrea
    CANCER TREATMENT REVIEWS, 2018, 64 : 11 - 20
  • [9] Healthcare resource utilization (HRU) in treated mantle cell lymphoma (MCL) patients
    Kozma, Chris M.
    Slaton, Terra
    Ellis, Lorie
    McKenzie, R. S.
    CANCER RESEARCH, 2014, 74 (19)
  • [10] Chemotherapy beyond immune checkpoint inhibitors in patients with metastatic colorectal cancer
    Romano, P. Martin
    Yolla, E. D.
    Capucine, B.
    Andrea, V.
    Perrine, V.
    Eric, A.
    Rastilav, B.
    Anas, G.
    Stephane, C.
    Pierre, A. Jean
    Sophie, P. V.
    Aurelien, M.
    Charles, S. Jean
    Michel, D.
    Valerie, B.
    David, M.
    Christophe, M.
    Antoine, H.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E80 - E80
12345